Cure My Disease

Don't miss your cure!

 Log in / Sign up

Listening to patients: a new way to guide prostate treatment?

NCT ID NCT05898932

Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study explores whether using detailed patient questionnaires can help doctors make better treatment decisions for men with an enlarged prostate, a condition called benign prostatic hyperplasia (BPH). The trial involves 300 men aged 50 and older who are either managing their condition with medication or have had surgery. Researchers will use new tools to track symptoms like urinary incontinence and overall quality of life, aiming to see if this patient-centered approach leads to less bothersome symptoms and better well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Patient-reported outcome tools and care-coordination checklists
What this could lead to
If successful, this could lead to more personalized and responsive care for men with enlarged prostate, potentially improving their quality of life and satisfaction with treatment.
What could go wrong
The trial is observational in nature, so it cannot prove cause and effect. Results may vary across different clinical settings, and the tools may not be widely adopted if they are burdensome for clinicians or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2023

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Men with benign prostatic hyperplasia

Ages

50 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male sex 2. Age 50 years or older 3. Diagnosed by physician with BPH 4. Able and willing to complete questionnaires 5. Able and willing to provide informed consent 6. Ability to read, write, and speak in English 7. No plans to move from study area in next 6 months Exclusion Criteria: 1. Female sex or intersex 2. Younger than 50 years of age 3. Being a prisoner or detainee 4. Gross hematuria 5. Interstitial cystitis 6. Pelvic or endoscopic genitourinary surgery within the preceding 6 months (not including diagnostic cystoscopy) 7. History of cystitis caused by tuberculosis, radiation therapy, or Cytoxan/cyclophosphamide therapy 8. Ongoing symptomatic urethral stricture 9. Current chemotherapy or other cancer therapy 10. History of lower urinary tract or pelvic malignancy 11. Severe neurological of psychiatric disorder that would prevent study participation (e.g., bipolar disorder, psychotic disorder, Alzheimer's Disease) 12. Current moderate or severe substance use disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostatic hyperplasia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Endeavor Health

    RECRUITING

    Glenview, Illinois, 60026, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.